| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af3d54c2537070d15bd96101c3cdeac7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-714 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate |
1981-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1982-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a0c2e6b96d77e79e4fd53a8f15ca564 |
| publicationDate |
1982-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4331145-A |
| titleOfInvention |
Multiple sclerosis treatment |
| abstract |
A treatment regime is described for multiple sclerosis comprising transcutaneous neuro-stimulation (TNS) and oral administration of d-phenylalanine. The d-phenylalanine prolongs the improvement from the TNS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5084007-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5401243-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5298019-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4574808-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4964848-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5183462-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295850-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007135522-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10493275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0056404-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0835660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7781486-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010274312-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013282079-A1 |
| priorityDate |
1981-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |